Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprolide Acetate and Spironolactone in PCOS and HAIR-AN Syndrome
NCT00004311Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- Jul 1989
- Modality
- Peptides, Small Molecules
01
Overview
Phase 2 trial of leuprolide and spironolactone in polycystic ovary syndrome (PCOS) and acanthosis nigricans (2 arms), sponsored by National Center for Research Resources. Primary endpoints: Insulin Resistance at 18 weeks and Insulin Secretion at 18 weeks. Started Jul 1989; status: completed.
02
Drugs
leuprolidespironolactone
03
Conditions
polycystic ovary syndrome (PCOS)acanthosis nigricans
Beyond the preview
Go deeper on NCT00004311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004311.